Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber
Clinical trial NCT02061709 · COMPLETED
Trial details
- NCT number
- NCT02061709
- Sponsor
- Circassia Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2014-10-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.